Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immulina TM for Immune Resilience to Influenza in Healthy Volunteers
NCT05447078Phase 3Completed
- Sponsor
- University of Mississippi Medical Center
- Start
- Jul 2022
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 3 trial of pidotimod in influenza, sponsored by University of Mississippi Medical Center. Started Jul 2022; status: completed.
02
Drugs
pidotimod
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05447078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447078.